6MK

Merck & Co., Inc. · XETR:6MK

132.48 EUR−1.84 −1.37%

Merck & Co., Inc. (XETR:6MK) last traded at 132.48 EUR, down 1.37% on the day. Over the past year the stock is up 76.88%. Its 52-week range is 71.40 to 136.44. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open133.48

Day range131.64 – 133.66

52-week range71.40 – 136.44

Volume734

Average volume (10 days)1.25 K

Market cap (USD)368.89 B

P/E153.27

EPS (TTM) (USD)0.9792

Dividend yield2.27%

Beta (1 year)0.3062

Revenue (TTM) (USD)67.19 B

Employees75.00 K

Performance

+1.63%1 week

+3.68%1 month

+19.61%3 months

+36.94%6 months

+47.86%Year to date

+76.88%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Merck Stocks Decline With Higher Target Leaving a New-Launch Scale TestGuruFocus · 02 Nov 2026
Merck Is Maintained at Neutral by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
Merck to Present New Data from Its Broad Oral HIV Portfolio and Pipeline at HIV Glasgow 2026BusinessWire · 02 Nov 2026
From Near Miss To Crown Jewel: The Rise, Reign And Road Ahead For Merck's Keytrudadpa-AFX · 01 Nov 2026
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Merck Price Target Raised to $175.00/Share From $165.00 by JP MorganDow Jones Newswires · 30 Oct 2026
Merck Stocks Rise 2.6% With Qlex Still Under 10% of Keytruda SalesGuruFocus · 30 Oct 2026
Merck One of Top Large-Cap Biopharma Picks-AnalystBenzinga · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.